BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 16911960)

  • 1. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm.
    Yang W; Yang H; Tien P
    FEBS Lett; 2006 Jul; 580(17):4231-5. PubMed ID: 16831424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UV-light-induced conversion and aggregation of prion proteins.
    Redecke L; Binder S; Elmallah MI; Broadbent R; Tilkorn C; Schulz B; May P; Goos A; Eich A; Rübhausen M; Betzel C
    Free Radic Biol Med; 2009 May; 46(10):1353-61. PubMed ID: 19249347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiautomated cell-free conversion of prion protein: applications for high-throughput screening of potential antiprion drugs.
    Breydo L; Bocharova OV; Baskakov IV
    Anal Biochem; 2005 Apr; 339(1):165-73. PubMed ID: 15766724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unfolding chaperone as a prion protein relating molecule].
    Hachiya NS; Sakasegawa Y; Kaneko K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.